Guizhou Chitianhua Co Ltd (600227.SS) stock: key figures, P/E, revenue and dividend
Materials · Fertilizers & Agricultural Chemicals · China · ISIN CNE0000011Q5
Guizhou Chitianhua Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.38 bn CNY | 2.16 bn CNY |
| Gross profit | 205.99 m CNY | 140.25 m CNY |
| Operating income | -76.79 m CNY | -95.10 m CNY |
| EBIT | -24.19 m CNY | -226.22 m CNY |
| Net income | -86.69 m CNY | -275.92 m CNY |
| Diluted EPS – continuing operations | -0.05 CNY | -0.16 CNY |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Guizhou Chitianhua Co Ltd
Guizhou Chitianhua Co.,Ltd. engages in the coal chemical, and pharmaceutical and health businesses in China. The company produces and sells urea, methanol, and compound fertilizers. It also provides medical services, including tumor diagnosis and treatment. In addition, the company engages in the mining and sale of coal, as well as provision of anthracite and thermal coal. Further, it is involved in the manufacture and sales of specialty chemical products; provision of technical development, consultation, exchanges, transfer, promotion, and services; coal washing; sales of coal products; import and export of technology, goods, and pharmaceuticals; motor vehicle repair and maintenance; health care products; Investment; health food production; production of foods for special medical purposes; sale of food, medical devices, disinfectants, hygiene, disposable medical supplies, internet, wearable smart devices; retail of medical masks and devices; pharmaceutical internet information services; internet platforms; internet security services; remote health management services; hospital management; psychological counseling services; medical research and experimental development; development and application of human stem cell technology; development of human gene diagnosis and treatment technology; drug clinical trial services; medical services; internet hospital services based on physical hospitals; medical device leasing; property management; medical device internet information services; professional cleaning, washing, and disinfection services; and parking services. The company was formerly known as Guizhou Salvage Pharmaceutical Co.,Ltd. and changed its name to Guizhou Chitianhua Co.,Ltd. in May 2023. The company was founded in 1998 and is based in Guiyang, China.
More stocks
- Channel Infrastructure Nz Limited (CHI.AX)
- Zhejiang Fore Intelligent Technology Co. Ltd. A (301368.SZ)
- SMARTFINANCIAL INC. (SMBK)
- Champion Iron Ltd (CIA.AX)
- Shantou Wanshun Package Material (300057.SZ)
- GR Engineering Services Ltd (GNG.AX)
- Shandong Jinjing Science and Technology Stock Co Ltd (600586.SS)
- Beyondsoft Corp (002649.SZ)
- Zbit Semiconductor Inc. A (688416.SS)
- Paysign, Inc. (PAYS)
- Array Technologies, Inc. (ARRY)
- OneSpan Inc. (OSPN)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.